Longitude Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
20

- Investments
-
172
- Portfolio
-
35
- Exits
-
105

Longitude Capital General Information
Company Description
Founded in 1997, Longitude Capital is a venture capital investment firm based in Menlo Park, California. The firm prefers to invest in start-ups to growth companies in the pharmaceuticals, biotechnology, healthcare devices, and life sciences sectors. The firm has additional offices in Greenwich and Boston. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.longitudecapital.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 2740 Sand Hill Road
- 2nd Floor
- Menlo Park, CA 94025
- United States
Longitude Capital Investments (172)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Cohere Health | 14-May-2025 | Later Stage VC | Enterprise Systems (Healthcare) | Generating Revenue | ||
MicroTransponder | 05-Mar-2025 | Therapeutic Devices | Generating Revenue | |||
Helicore Biopharma | 16-Jan-2025 | Drug Discovery | Pre-Clinical Trials | |||
Aviceda Therapeutics | 07-Jan-2025 | Biotechnology | Clinical Trials - Phase 2 | |||
Fire1 | 07-Jan-2025 | Monitoring Equipment | Generating Revenue | |||
VeraDermics | 11-Dec-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
Alentis Therapeutics | 11-Nov-2024 | Drug Discovery | Clinical Trials - Phase 2 | |||
Alpha-9 Oncology | 23-Oct-2024 | Biotechnology | Pre-Clinical Trials | |||
Nalu Medical | 09-Oct-2024 | Later Stage VC | Therapeutic Devices | Generating Revenue | ||
OrsoBio | 28-Aug-2024 | Early Stage VC | Biotechnology | Clinical Trials - Phase 2 |
Longitude Capital Exits (105)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Bolt Medical | 28-Apr-2025 | Merger/Acquisition | |
Kestra Medical Technologies | 06-Mar-2025 | ||
AEON Biopharma | 07-Jan-2025 | ||
CG Oncology | 13-Dec-2024 | ||
Vera Therapeutics | 30-Oct-2024 | ||
Ceribell | 11-Oct-2024 | ||
BioAge Labs | 26-Sep-2024 | ||
Zenas BioPharma | 13-Sep-2024 | ||
Avenge Bio | 01-Aug-2024 | Out of Business | |
Tourmaline Bio | 26-Jan-2024 | Public Investment 2nd Offering |
Longitude Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Longitude Capital Investments by Industry, Year, and Region
Longitude Capital Co-Investors (218)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
RA Capital Management | 9 |
![]() |
![]() |
||
OrbiMed |
![]() |
![]() |
|||
Janus Henderson Investors |
![]() |
![]() |
|||
Omega Funds |
![]() |
![]() |
|||
T. Rowe Price Group |
![]() |
![]() |
Longitude Capital FAQs
-
What is Longitude Capital?
Founded in 1997, Longitude Capital is a venture capital investment firm based in Menlo Park, California.
-
When was Longitude Capital founded?
Longitude Capital was founded in 1997.
-
Where is Longitude Capital headquartered?
Longitude Capital is headquartered in Menlo Park, CA.
-
What is Longitude Capital's total asset value?
Longitude Capital has around
in total assets under management. -
How many investments has Longitude Capital made?
Longitude Capital has made 172 investments.
-
What has Longitude Capital invested in?
Longitude Capital has made numerous investments in companies like Cohere Health, MicroTransponder, and Helicore Biopharma within the Enterprise Systems (Healthcare), Therapeutic Devices, and Drug Discovery industries.
-
What has Longitude Capital invested in recently?
Longitude Capital's latest investment was on 14-May-2025 in Cohere Health, a company within the Enterprise Systems (Healthcare) industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »